Forefront Wealth Management Inc. Autolus Therapeutics PLC Transaction History
Forefront Wealth Management Inc.
- $114 Million
- Q2 2025
A detailed history of Forefront Wealth Management Inc. transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Forefront Wealth Management Inc. holds 26,870 shares of AUTL stock, worth $62,338. This represents 0.05% of its overall portfolio holdings.
Number of Shares
26,870Holding current value
$62,338% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding AUTL
# of Institutions
98Shares Held
163MCall Options Held
0Put Options Held
88.3K-
Wellington Management Group LLP Boston, MA27.1MShares$62.9 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$47.5 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$41.4 Million0.97% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$38.6 Million98.24% of portfolio
-
Armistice Capital, LLC New York, NY11MShares$25.5 Million0.26% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $211M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...